T1	Participants 178 238	patients with locally advanced noninflammatory breast cancer
T2	Participants 427 512	patients with locally advanced breast cancer treated with chemotherapy and mastectomy
T3	Participants 559 625	200 patients with clinical Stage III noninflammatory breast cancer
T4	Participants 723 790	179 patients treated with mastectomy after neoadjuvant chemotherapy
